ロード中...
Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir
Saquinavir, a potent human immunodeficiency virus protease inhibitor, is extensively metabolized by CYP3A4. Saquinavir is coadministered with ritonavir, a strong CYP3A4 inhibitor, to boost its exposure. Ketoconazole is a potent CYP3A inhibitor. The objectives of this study were to investigate the ef...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2630604/ https://ncbi.nlm.nih.gov/pubmed/19015329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00769-08 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|